boulder county infectious disease surveillance update
play

Boulder County Infectious Disease Surveillance Update Community - PowerPoint PPT Presentation

Boulder County Infectious Disease Surveillance Update Community Infectious Disease Emergency Response Meeting 8.21.2018 Reportable Conditions Investigated by BCPH 46% compared to 5 800 250 year average (2012-2016) Total Cases Rate


  1. Boulder County Infectious Disease Surveillance Update Community Infectious Disease Emergency Response Meeting 8.21.2018

  2. Reportable Conditions Investigated by BCPH 46% compared to 5 800 250 year average (2012-2016) Total Cases Rate per 100,000 700 200 600 Number of Cases Rate per 100,000 21% compared to 500 Pertussis Epidemic Year 150 Pertussis Epidemic Year pertussis epidemic year 400 100 300 (2013) 200 50 100 0 0 2012 2013 2014 2015 2016 2017

  3. Total Number of Reportable Conditions Investigated 2018 Compared to 5 Year Average 160 8% compared to 140 5 Year Average (2013-2017) 2017 YTD 2018 120 Number of Cases 100 80 60 40 20 0

  4. 2017-2018 Influenza Season Recap • High severity, H3N2-predominant season with record-breaking level of influenza-like illness and hospitalizations. • Between October 1, 2017-May 26, 2018 – 4,675 hospitalizations statewide/ 260 in Boulder County – 183 outbreaks/14 in Boulder County (Assisted and Skilled Nursing) – One pediatrics death in the state – One novel influenza A variant (H1N2v)

  5. 2018-2019 Influenza Season What communications/data going into and during the 2018-2019 Influenza season would be helpful to you/your organization?

  6. Common Reportable Conditions (January 1, 2018-July 31, 2018) 8 Vibrio 4 4 Shigella 6 Cyclospora: 100% out of state (3)/country (5) 17 Yersinia 7 1 Cyclospora Cryptosporidium: 56% out of state (3)/country (9) 8 9 Shiga-toxin producing E.Coli 17 5-YR Mean (2013-2017) YTD STEC: 59% out of state (1)/country (9) 6 Cryptosporidium 2018 YTD 19 17 Salmonella 22 Campylobacter: 65% out of state (11)/country (32) 24 Giardia 23 57 Pertussis 43 47 Campylobacter 66 0 10 20 30 40 50 60 70

  7. Campylobacter Surveillance 40 35 Boulder CO CO 30 Rate per 100,000 25 20 15 10 Healthy People 2020 Goal 5 0 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018

  8. Enteric Pathogen Testing in Boulder County

  9. Colorado Rabies Update • 277 specimens have tested positive for rabies in Colorado. – 202 skunks, 63 bats, 3 raccoons, 1 alpaca, 8 cat/dog – Boulder County: bat (2); skunk (1) • This number of positive animals surpasses the previous season high of 191 in 2013. • Of 277 rabid animals, 132 were known or strongly suspected of exposing 277 domestic pets, 92 livestock and 86 people. • Rabies risk assessments and rabies PEP recommendations have been made for 24 Boulder County residents thus far this year.

  10. West Nile Virus Activity by State, 2018 *August 7, 2018

  11. Colorado West Nile Virus Update • 8 cases of human West Nile Virus (WNV) have been reported/confirmed as of August 20, 2018 in Delta (1), Larimer (4) and Weld (3) counties. – uncomplicated fever cases (67%) – meningoencephalitis case (33%) – No fatalities have been reported • 85 mosquito pools tested positive state-wide and were collected from Adams (2), Boulder (10), Larimer (53), and Weld (20)

  12. U.S.-Based Ongoing Outbreak Update June 2018: Multistate Multistate (10) Outbreak (44) Outbreak of August 2018: Multistate Salmonella (Live poultry) of Hepatitis A (15) Outbreak of Cyclosporiasis (McDonalds) June 2018: Multistate (9) Outbreak of Salmonella (Pre-cut July 2018: Multistate (9) melon) Outbreak of Salmonella (Pasta Salad) July 2018: Multistate (26) Outbreak of Salmonella (Ground June 2018: Multistate Turkey) (33) Outbreak of Salmonella (Honey July 2018: Multistate (4) Smacks) Outbreak of Vibrio parahaemolyticus (Crab meat)

  13. Hepatitis A Outbreak Continues in Multiple States Across the U.S. • CDC and state health departments continue to investigate HAV outbreaks in multiple states among persons reporting injection drug use and/or experiencing homelessness and their contacts. • Colorado returned back to baseline rates of reported hepatitis A cases in November 2017 (~30/year). • Eight cases of hepatitis A have been reported in Colorado in 2018; and one case was both experiencing homelessness and reported injection drug use. No cases have been reported in Boulder County in 2018. • • BCPH continues to provide the Hepatitis A vaccines at the Boulder Shelter and at BCPH- walk-in, appointment and during regular clinic hours.

  14. Enterovirus A71 (EV-A71) Update CDPHE continues to investigate a number of cases of neurologic • disease (meningitis, encephalitis, acute flaccid myelitis) associated with enterovirus A71 (EV-A71) infection in children. Cases are all under age 3 years with no underlying medical • conditions. Symptoms include fever, irritability, myoclonus, ataxia, rash, weakness, vomiting, and diarrhea. • Consider collecting throat, rectum and cerebrospinal fluid (CSF) samples from children with aseptic meningitis, encephalitis, or other central nervous system infections for enteroviral PCR testing. – EV-A71 is often not detected by PCR in CSF, so CDPHE recommends simultaneous testing from all three sites. • Please report all cases of meningitis, encephalitis, AFM, or other neurologic complications in patients who test positive for enterovirus to CDPHE.

  15. Antibiotic Resistant Bacteria Surveillance Updates

  16. Recent carbapenem-resistant bacteria surveillance changes November 2015: Carbapenem-resistant July 2018: Pseudomonas Additional CRE aeruginosisa ( CRPA) organisms: Citrobacter , statewide lab Serratia , Raoultella , January 2016: reportable condition Proteus , Providencia , CRE definition and Morganella ; AND change carbapenemase- producing CRE (CP-CRE) of any genus/species November 2012: reportable Carbapenem-resistant Enterobacteriaceae (CRE) statewide lab reportable condition Carbapenem-resistant Acinetobacter baummannii (CRAB) reportable in the 5-county Denver metro area

  17. Extended-spectrum beta-lactamases (ESBLs) Surveillance in Boulder • ESBLs are enzymes that mediate resistance to extended-spectrum (third generation) cephalosporins (e.g., cefotaxime, ceftriaxone) and monobactams (e.g., aztreonam) but do not affect cephamycins (e.g., cefoxitin and cefotetan) or carbapenems (e.g., meropenem or imipenem). • ESBLs became reportable in Boulder County starting July 15, 2018.

  18. Antimicrobial Stewardship • The first Colorado Antibiogram is nearly complete. – Publically available tool of antibiotic stewardship that will inform population level antibiotic stewardship strategy – Summary of susceptibility of bacteria cultured from clinical specimens in 2016 – Data pooled from antibiogram of individual hospitals (N=66), skilled nursing (n=86), and assisted living facilities (n=170)

  19. Questions?

Recommend


More recommend